Patent: 7,713,521
✉ Email this page to a colleague
Summary for Patent: 7,713,521
Title: | MCP1 fusions |
Abstract: | The present invention provides polypeptides including MCP1 fused, optionally, by a linker, to an immunoglobulin. Methods for using the polypeptides to treat medical disorders are also covered. |
Inventor(s): | Chou; Chuan-Chu (Westfield, NJ), Bober; Loretta A. (Linden, NJ), Sullivan; Lee (Somerset, NJ) |
Assignee: | Schering Corporation (Kenilworth, NJ) |
Application Number: | 11/502,064 |
Patent Claims: | see list of patent claims |
Details for Patent 7,713,521
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 08/24/1998 | ⤷ Try a Trial | 2025-08-12 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 11/02/1998 | ⤷ Try a Trial | 2025-08-12 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 05/27/1999 | ⤷ Try a Trial | 2025-08-12 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |